Sickle Cell Disease News and Research

Latest Sickle Cell Disease News and Research

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Regenacy Pharmaceuticals partners with CMTA to advance ricolinostat for treating hereditary neuropathy

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Therapy with L-Glutamine reduces pain in patients with sickle cell disease

Researchers identify enzyme as potential new drug target for blood disorders

Researchers identify enzyme as potential new drug target for blood disorders

CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought

CRISPR/Cas9 gene editing can cause greater genetic damage than previously thought

New guideline recommends first-trimester screening of pregnant women for asymptomatic bacteriuria

New guideline recommends first-trimester screening of pregnant women for asymptomatic bacteriuria

Music therapy shows promise for improving lives of people with sickle cell disease

Music therapy shows promise for improving lives of people with sickle cell disease

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Acetaminophen use helps reduce acute kidney injury risk in pediatric heart surgery patients

Study: Stigmatizing language in medical records may play a role in how the patient is treated

Study: Stigmatizing language in medical records may play a role in how the patient is treated

Doctors cure sickle cell patients using allogeneic stem cells

Doctors cure sickle cell patients using allogeneic stem cells

Pitt researcher secures nearly $5 million NIH funding for 'Tic-Tac-Toe' RF coil system

Pitt researcher secures nearly $5 million NIH funding for 'Tic-Tac-Toe' RF coil system

Using Cord Blood to Alleviate the Symptoms of Autism

Using Cord Blood to Alleviate the Symptoms of Autism

Genetic mutation that may protect people from malaria found to be more common

Genetic mutation that may protect people from malaria found to be more common

University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain research

University of Illinois at Chicago awarded $4.6 million NIH grant for chronic pain research

Study reveals HCT as effective treatment for NHL patients regardless of age

Study reveals HCT as effective treatment for NHL patients regardless of age

Combination chemotherapy increases survival in animal models of glioblastoma

Combination chemotherapy increases survival in animal models of glioblastoma

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Sangamo and Pfizer partner for development of new zinc finger protein gene therapy to treat ALS

Strategies to prevent and treat acute chest syndrome in children with sickle cell disease

Strategies to prevent and treat acute chest syndrome in children with sickle cell disease

Sickle cell patients, families and doctors face a ‘fight for everything’

Sickle cell patients, families and doctors face a ‘fight for everything’

Researchers find link between negative emotions and higher opioid use in people with sickle cell disease

Researchers find link between negative emotions and higher opioid use in people with sickle cell disease

Increasing hydroxyurea dose linked to reduction in hospitalization for young sickle cell anemia patients

Increasing hydroxyurea dose linked to reduction in hospitalization for young sickle cell anemia patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.